SynthesisJournal of neuro-oncology2019

Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes.

Victor M Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.